We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Jan 20
Biogen will pay an upfront payment of $75m and additional development and commercialisation milestone payments of up to…
Increasing numbers of people experiencing mental health problems like depression and anxiety in the UK has led to…
09 Jan 20
The partnership is aimed at exploring potential new therapies encompassing autoimmune, infectious and idiopathic disorders, using SAB’s DiversitAb…
New trends like AI and machine learning, along with huge breakthroughs in the medical devices sector, have made…
11 Dec 19
Imperative Care has secured the US Food and Drug Administration (FDA) 510(k) approval for its family of access…
09 Dec 19
AVSOLA is an anti-tumour necrosis factor alpha (anti-TNF) monoclonal antibody, which is very similar to Remicade and has…
29 Nov 19
Novartis will manufacture Kymriah and other CAR-T cell therapies and gene therapies at the new factory
29 Nov 19
The FDA has accepted AstraZeneca’s sBLA for Imfinzi based on positive results from the phased III CASPIAN trial
28 Nov 19
The acquisition forms part of Asahi Kasei’s plan to accelerate its transformation into a global healthcare company
26 Nov 19
FerGene, a new gene therapy firm, will be established as a subsidiary of Ferring, to commercialise bladder cancer…